Can I get Mounjaro from my GP on the NHS?

NHS GP prescribing for Mounjaro began in June 2025, but the rollout is phased — current eligibility requires a BMI of 40 or above plus four or more specific weight-related conditions.
GP participation in the new prescribing scheme is optional, so access varies by practice and area even when you meet the clinical criteria.
Every NHS patient who receives Mounjaro must also take part in structured diet and activity support; the medicine alone is not prescribed in isolation.
Private prescriptions through a GPhC-registered online pharmacy offer an alternative route for adults who are clinically eligible but do not yet meet NHS thresholds or prefer not to wait.

Yes, GPs in England can now prescribe Mounjaro (tirzepatide) on the NHS, but only under a phased rollout with strict clinical criteria — most people asking this question today will not yet qualify. The criteria tightened by design, and many adults who would benefit medically are still outside the current eligibility window. This page explains exactly where the NHS rollout stands, what your GP can and cannot do right now, and what the private route looks like if you do not want to wait.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How NHS GP prescribing for Mounjaro actually works in 2025 and 2026

The myth: 'My GP can prescribe Mounjaro for weight loss whenever they think it's right'

This is the misunderstanding our prescribers hear most weeks. Many people assume that once a medicine is licensed, any GP can simply write a prescription for it on clinical grounds. With Mounjaro, that is not how NHS prescribing currently operates. NICE published its recommendation for tirzepatide in Technology Appraisal TA1026 in December 2024, but the NHS England commissioning guidance sits behind a phased rollout that restricts which patients can access the treatment through the health service, and when.

From June 2025, the first phase opened for adults with a BMI of 40 or above who also have four or more of five specific weight-related conditions: type 2 diabetes, high blood pressure, dyslipidaemia, obstructive sleep apnoea, and cardiovascular disease. That is a deliberately narrow group. Cohort 2, covering adults with a BMI between 35 and 39.9 alongside four or more of those conditions, became eligible from 23 June 2026. Lower BMI thresholds apply for people of South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, where the threshold is reduced by 2.5 kg/m² throughout. You can check where your own BMI sits against the current thresholds using the NHS BMI calculator.

Even within those groups, your GP's practice has to have opted in to the prescribing scheme under the QOF 2026/27 GP contract. Participation is voluntary. A practice that has not yet signed up cannot issue an NHS prescription for Mounjaro regardless of your BMI or comorbidities.

What happens at a GP appointment if you ask about Mounjaro

A GP who has opted in will review your medical history, confirm your BMI and comorbidities against the current phase criteria, and check whether the wrap-around dietary and lifestyle support is in place. That last point matters: NHS commissioning requires patients to engage with structured behaviour-change support alongside the medicine. If your practice has not yet set up that support pathway, the prescription cannot go ahead even if you personally tick every clinical box.

For anyone falling outside the current phase criteria, a GP can note your interest and flag you for a later cohort, but they cannot prescribe Mounjaro on the NHS today simply because they agree it would benefit you. That restriction is commissioning policy, not clinical opinion. It is one of the reasons many people look into the GP prescribing criteria in more detail before their appointment, so they are not left surprised.

It is also worth knowing that the criteria for private prescriptions differ from NHS thresholds. The licensed eligibility for tirzepatide as a weight-management medicine covers adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as prediabetes, hypertension or high cholesterol. A prescriber assesses the full clinical picture; BMI alone does not determine the outcome. More detail on how eligibility is assessed is on the Mounjaro BMI eligibility page.

If your GP cannot prescribe it yet, what are your options?

Waiting for the NHS rollout is entirely reasonable if you meet later-phase criteria and your GP is already enrolled. The phased expansion is planned to continue through 2027, broadening access step by step. The NHS route means the medicine is covered, and the clinical oversight is built in.

The private route is the alternative for people who do not yet meet NHS thresholds, whose practice has not opted in, or who would rather not wait. A GPhC-registered online pharmacy can accept a private consultation and, if a prescriber determines you are clinically suitable, issue a private prescription. Mounjaro is a prescription-only medicine in the UK: there is no legal route to it without a clinical assessment and a prescription from a qualified prescriber. Our Mounjaro overview page covers how the medicine works and what the clinical trial evidence shows.

On cost: private treatment is a genuine commitment. The cost of Mounjaro privately varies by dose and provider, and it is worth reading what different services actually include before choosing one. Some headline prices exclude the consultation, prescription, delivery or aftercare support; a complete picture matters more than the lowest number on a comparison page.

If you are already receiving treatment elsewhere and are thinking about continuity, it helps to understand your options around pausing Mounjaro and what that means clinically. It is also a separate but related question to getting tirzepatide from a doctor more broadly, which covers both NHS and private GP routes.

When you are ready to explore whether private treatment is right for you, speak to our prescribers through a free consultation. A real clinician reads every submission the same day; no algorithm decides your suitability.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions